Evidence-based guidelines for the treatment of chronic-phase chronic myeloid leukemia Richard T Silver

In this chapter, I shall review evidence-based clinical practice guidelines (EB-CPGs) in general, discuss how they apply to chronic myeloid leukemia (CML) in particular, and emphasize the importance of shared decision-making. In closing, I shall discuss the effect of the new signal transduction inhibitor STI571 on the process to date.